Rif1 Regulates Self-Renewal and Impedes Mesendodermal Differentiation of Mouse Embryonic Stem Cells

Cheng Liu1, Peng Yu1, Zongna Ren2

  • 1State Key Laboratory of Cardiovascular Disease, Key Laboratory of Application of Pluripotent Stem Cells in Heart Regeneration, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 North Lishi Road, 100037, Beijing, China.

Abstract

Insights

RAP1 interacting factor 1 (Rif1) is crucial for mouse embryonic stem cell (mESC) pluripotency and self-renewal. Loss of Rif1 promotes mESC differentiation by affecting EZH2 occupancy and activating ERK1/2 signaling.

Area of Science:

  • Developmental Biology
  • Epigenetics
  • Stem Cell Biology

Background:

  • RAP1 interacting factor 1 (Rif1) is highly expressed in mouse embryos and embryonic stem cells (mESCs).
  • Rif1 is known to regulate telomere length, DNA damage, replication timing, and ERV silencing.
  • Its role in early mESC differentiation remained unclear.

Purpose of the Study:

  • To investigate the role of Rif1 in the early differentiation of mouse embryonic stem cells (mESCs).
  • To elucidate the molecular mechanisms by which Rif1 influences mESC self-renewal and pluripotency.

Main Methods:

  • Generated a Rif1 conditional knockout mESC line using the Cre-loxP system.
  • Employed techniques including Western blot, flow cytometry, qRT-PCR, RNA-Seq, and ChIP-Seq.
  • Utilized immunofluorescence and immunoprecipitation for molecular mechanism assessment.

Main Results:

  • Rif1 is essential for mESC self-renewal and pluripotency; its loss promotes differentiation towards mesendodermal lineages.
  • Rif1 interacts with EZH2 (a PRC2 subunit) and regulates developmental gene expression via promoter binding.
  • Rif1 deficiency decreases EZH2 and H3K27me3 occupancy on mesendodermal gene promoters and activates ERK1/2 signaling.

Conclusions:

  • Rif1 is a key regulator of mESC pluripotency, self-renewal, and lineage specification.
  • Rif1 bridges epigenetic regulation (EZH2) and signaling pathways (ERK1/2) in mESC fate determination.